Daily non-political popular news in brief.

Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors

A study in the Jan. 3 issue of the Journal of the National Cancer Institute quantifies the risk of hereditary retinoblastoma survivors developing specific subtypes of soft tissue sarcomas and finds that this risk persists for decades after the original retinoblastoma diagnosis. The findings emphasize the importance of regular medical surveillance for these patients, the authors say.

Read more »

Keywords: study, examines, risk, soft, tissue, sarcomas, hereditary, retinoblastoma, survivors, examine, sarcoma, survivor

« Previous | Next »

Similar news on "Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors":

1. Childhood cancer survivors at increased risk of sarcoma
   02-20-2007 · EurekAlert!
   Survivors of childhood cancers have a ninefold increased risk of developing a secondary sarcoma -- a cancer of connective or supportive tissue such as bone, fat, or muscle -- compared with the general population, according to a study in the February 21 Journal of the National Cancer Institute.
   Similar news · Read more »
   
2. Co-operation between GSF and clinic improves outlook for sarcoma patients
   07-13-2007 · EurekAlert!
   Hyperthermia, combined with chemotherapy, improves the chances of healing and survival of patients with low-lying, soft tissue sarcomas. At the Annual General Meeting of the American Society of Clinical Oncology in Chicago, the GSF scientist Professor Dr. Rolf D. Issels, presented the results of the first, randomized worldwide phase III study in which the effectiveness and superiority of the combined-therapy methods are proven, in comparison with results from chemotherapy alone.
   Similar news · Read more »
   
3. Survey finds perceived risk of recurrence low in African-American breast cancer survivors
   02-15-2007 · EurekAlert!
   A unique survey of African-American breast cancer survivors at heightened risk for hereditary breast cancer has found the majority do not believe they have an increased chance of developing the cancer again. A study in this month's Cancer Epidemiology, Biomarkers & Prevention, suggests it is important to ensure that African-American women understand their risk of developing cancer, and genetic counseling to address cultural beliefs and values may be one way of doing so.
   Similar news · Read more »
   
4. Disparities among patients with extremity soft-tissue sarcomas
   01-22-2008 · EurekAlert!
   A new study reveals significant racial and ethnic differences in the treatment and survival of patients with soft-tissue sarcomas, a rare but dangerous cancer that begins in muscle, fat, blood vessels or other supporting tissue of the body.
   Similar news · Read more »
   
5. Patients with soft tissue sarcomas should be treated at high volume centers
   07-09-2007 · EurekAlert!
   Soft tissue sarcomas -- rare tumors of the connective tissue -- should be treated at the few centers which see most cases, in order to give patients the best chance of good outcomes, concludes an analysis of sarcoma management in Florida, published in the Annals of Surgery last month.
   Similar news · Read more »
   
6. Study of leukemia survivors gives hints for better care
   03-20-2007 · EurekAlert!
   Results from the longest follow-up study ever done of childhood acute lymphoblastic leukemia (ALL) survivors show the importance of long-term monitoring of former patients to identify complications they are at risk for developing later in life and to modify current treatments to reduce those risks, according to investigators at St. Jude Children's Research Hospital.
   Similar news · Read more »
   
7. Diet and exercise key to surviving breast cancer, regardless of obesity, new UCSD study says
   06-08-2007 · EurekAlert!
   Breast cancer survivors who eat a healthy diet and exercise moderately can reduce their risk of dying from breast cancer by half, regardless of their weight, suggests a new longitudinal study from the Moores Cancer Center at the University of California, San Diego.
   Similar news · Read more »
   
8. CTRC enrolls first patients in Novel Phase II study for sarcoma -- Living virus destroys cancer cell
   07-24-2007 · EurekAlert!
   The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung. The novel anti-cancer therapy, REOLYSIN, is a living virus, not a chemotherapy drug, that is toxic to cancer cells but not harmful to normal cells.
   Similar news · Read more »
   
9. Studies highlight MRSA evolution and resilience
   01-21-2008 · EurekAlert!
   Community-associated methicillin-resistant Staphylococcus aureus infections are caused primarily by a single strain -- USA300 -- of an evolving bacterium that has spread with "extraordinary transmissibility" throughout the United States during the past five years, according to a new study led by National Institutes of Health scientists. CA-MRSA, an emerging public health concern, typically causes readily treatable soft-tissue infections such as boils, but also can lead to life-threatening conditions that are difficult to treat.
   Similar news · Read more »
   
10. Research linking Ashkenazi Jews & breast cancer genes beset by problems
    11-01-2006 · EurekAlert!
    Genetic research over the past decade has linked Ashkenazi Jewish ethnicity to an increased risk for hereditary breast cancer, so much so that certain gene mutations have become known as "Jewish ancestral mutations." But a new study released in the November 2006 issue of the American Journal of Public Health challenges this population-based approach, warning that disparities in access to care and other unintended consequences for specific ethic groups can result, and may have already occurred.
    Similar news · Read more »